why choose us

First received: May 31, 2023

Clinical Trial: A Study to Learn About the Study Medicine (Maplirpacept) in People With Advanced Non-Hodgkin Lymphoma or Multiple Myeloma in China

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Non-Hodgkin Lymphoma

Study Type: INTERVENTIONAL


Official Title: AN OPEN-LABEL, PHASE 1 STUDY EVALUATING THE PHARMACOKINETICS, SAFETY AND ANTI-TUMOR ACTIVITY OF PF-07901801 (TTI-622) MONOTHERAPY IN CHINESE PARTICIPANTS WITH ADVANCED HEMATOLOGIC MALIGNANCIES

Brief Summary: The purpose of this study is to learn about the safety and what the body does to the medicine (Maplirpacept) when taken for the treatment of non-Hodgkin lymphoma or multiple myeloma.Non-Hodgkin lymphoma is any of a large group of cancers of lymphocytes (white blood cells).Multiple myeloma is a type of cancer that begins in plasma cells (white blood cells that produce antibodies).This study is seeking participants who:have non-Hodgkin lymphoma or multiple myeloma.have worsened with (or lack of improvement to) a…

Read more